Cargando…

Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment

Detalles Bibliográficos
Autores principales: Yano, H., Nakano, R., Suzuki, Y., Nakano, A., Kasahara, K., Hosoi, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Healthcare Infection Society. Published by Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547371/
https://www.ncbi.nlm.nih.gov/pubmed/33049366
http://dx.doi.org/10.1016/j.jhin.2020.10.004
_version_ 1783592406282665984
author Yano, H.
Nakano, R.
Suzuki, Y.
Nakano, A.
Kasahara, K.
Hosoi, H.
author_facet Yano, H.
Nakano, R.
Suzuki, Y.
Nakano, A.
Kasahara, K.
Hosoi, H.
author_sort Yano, H.
collection PubMed
description
format Online
Article
Text
id pubmed-7547371
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Healthcare Infection Society. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75473712020-10-13 Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment Yano, H. Nakano, R. Suzuki, Y. Nakano, A. Kasahara, K. Hosoi, H. J Hosp Infect Letter to the Editor The Healthcare Infection Society. Published by Elsevier Ltd. 2020-12 2020-10-10 /pmc/articles/PMC7547371/ /pubmed/33049366 http://dx.doi.org/10.1016/j.jhin.2020.10.004 Text en © 2020 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Yano, H.
Nakano, R.
Suzuki, Y.
Nakano, A.
Kasahara, K.
Hosoi, H.
Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment
title Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment
title_full Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment
title_fullStr Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment
title_full_unstemmed Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment
title_short Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment
title_sort inactivation of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) by gaseous ozone treatment
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547371/
https://www.ncbi.nlm.nih.gov/pubmed/33049366
http://dx.doi.org/10.1016/j.jhin.2020.10.004
work_keys_str_mv AT yanoh inactivationofsevereacuterespiratorysyndromecoronavirus2sarscov2bygaseousozonetreatment
AT nakanor inactivationofsevereacuterespiratorysyndromecoronavirus2sarscov2bygaseousozonetreatment
AT suzukiy inactivationofsevereacuterespiratorysyndromecoronavirus2sarscov2bygaseousozonetreatment
AT nakanoa inactivationofsevereacuterespiratorysyndromecoronavirus2sarscov2bygaseousozonetreatment
AT kasaharak inactivationofsevereacuterespiratorysyndromecoronavirus2sarscov2bygaseousozonetreatment
AT hosoih inactivationofsevereacuterespiratorysyndromecoronavirus2sarscov2bygaseousozonetreatment